These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 28644)

  • 1. [Pharmacologic differentiation between various anti-arrhythmics in animal experiments].
    Lillie C; Kobinger W
    Adv Clin Pharmacol; 1978; 16():3-16. PubMed ID: 28644
    [No Abstract]   [Full Text] [Related]  

  • 2. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of anti-arrhythmics on the sinus rhythm. Evaluation using long-term electrocardiographic recordings quantified by the Atrec system].
    Leclercq JF; Rosengarten MD; Attuel P; Kural S; Milosevic D; Coumel P
    Arch Mal Coeur Vaiss; 1980 Aug; 73(8):903-11. PubMed ID: 6106463
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of 17-monochloro-acetylajmaline, a new anti-arrhythmia drug, upon myocardial contractility].
    Bardet J; Roudy G; Rocha P; Riguad M; Mathivat A; Bourdarias JP
    Ann Cardiol Angeiol (Paris); 1974; 23(6):539-44. PubMed ID: 4618072
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of denudatine on experimental arrhythmia and heart function (author's transl)].
    Jin LS; Zhou YP; Zeng GY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):104-8. PubMed ID: 6214142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Change of the fibrillation threshold of the heart of spontaneously breathing guinea pigs in hypothermia].
    Kirsch U
    Arzneimittelforschung; 1969 Mar; 19(3):312-3. PubMed ID: 5818779
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
    Howard PG; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():123-7. PubMed ID: 2274522
    [No Abstract]   [Full Text] [Related]  

  • 10. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative studies on the influence of different anti-arrhythmic drugs on the alpha- and beta-receptors in cat blood pressure test.
    Sándor P; Kovách GB
    Arzneimittelforschung; 1968 Oct; 18(10):1287-9. PubMed ID: 4388277
    [No Abstract]   [Full Text] [Related]  

  • 12. Do related kappa agonists produce similar effects on cardiac ion channels?
    Pugsley MK; Hayes ES; Saint DA; Walker MJ
    Proc West Pharmacol Soc; 1995; 38():25-7. PubMed ID: 7480011
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute toxicity and general pharmacologic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane: DA 1686.
    Turba C; Sanna GP; Bianchi C
    Arzneimittelforschung; 1968 Sep; 18(9):1127-32. PubMed ID: 4387882
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 16. [Central machanisms involved in anti-arrhythmic action of vanilol].
    Xiao JG; Yuan XR; Chen X; Liu TP
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):103-6. PubMed ID: 6225294
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of anti-anginal drugs on AV-conduction in normal subjects.
    Neuss H; Nowak FG; Schlepper M; Wüsten B
    Arzneimittelforschung; 1974 Feb; 24(2):213-6. PubMed ID: 4150916
    [No Abstract]   [Full Text] [Related]  

  • 18. [Actions of sparteine and sparteine derivatives on the heart and circulation].
    Raschack M
    Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro myocardial effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956).
    Kline RL; Buckley JP
    J Pharmacol Exp Ther; 1972 Sep; 182(3):399-408. PubMed ID: 4403432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.